Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
13 Cards in this Set
- Front
- Back
breakthrough dosing of a long-acting regimen
|
10% of the total daily dose q1h prn
|
|
breakthrough dosing of a short-acting regimen
|
50% of the intermittent dose q1h prn
|
|
what is initial tx for an opioid naive patient with a score of 1-3 (mild)
|
consider NSAIDs or APAP
co-analgesics PRN bowel regimen |
|
what is initial tx for an opioid naive patient with a score of 4-6 (moderate)
|
titrate SA opioid
co-analgesics prn bowel regimen |
|
what is initial tx for an opioid naive patient with a score of 7-10 (severe)
|
rapid titration of SA opioids
co-analgesics prn bowel regimen |
|
in an opioid tolerant patient with a pain score of 1-3, an appropriate step is to
|
convert from IR to ER formulation and adjust the BT dosing
opioid rotation if intolerable side effects |
|
cancer pain syndrome: inflammation
high risk patients include monitor: |
inflammation
- tumor/mets location - pleural/peritoneal mets high risk: renal complications of NSAIDs, age > 60, dehydrated, interstitial nephritis, papillary necrosis; nephrotoxic drugs (Cyclosporin, cisplatin, any renally excreted chemo) monitor BP, renal function, fecal occult |
|
cancer pain syndrome: inflammation
treatment? |
trial of NSAIDs/glucocorticoid
ibuprofen, ketorolac use medications that don't inhibit platelet aggregation - choline + mag salicylate - cox 2 inhibitor |
|
cancer pain syndrome: nerve compression
|
bone mets in spinal cord, tumor invasion, treatment-induced osteoporosis
treatment: dexamethasone, either burst or maintenance therapy |
|
cancer pain syndrome: bone pain
|
primrary tumor or mets sprad
local bone pain: - palliative radiation - nerve block Diffuse bone pain - bisphosphonate trial steroids (dexamethasone) nsaid/cox-2/apap |
|
in the treatment of cancer pain syndrome: bone pain, what is the difference between dexamethasone and prednisone
|
dex causes better bone penetration, less fluid retention
|
|
if using zoledronic acid (Zometa) as a treatment for bone pain, what should be done
|
give apap or benadryl to prevent infusion reaction
adjust the dose renally |
|
what is Metastron (strontinum)
|
systemic radionuclide therapy for bone pain
and IV infusion that provides pain relief for 3-6 months, although it does cause an initial increase in pain for 2-3 days considered when the person has multiple remote bone lseions and a life expectancy of <6 months and unable to tolerate systemic pharmacotherapy or it is refractory |